Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of OT-802 eye drops for presbyopia in Chinese adults
CTR20261783Phase 3Active
- Sponsor
- Ocumension Biotech
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pilocarpine in presbyopia, sponsored by Ocumension Biotech. Started May 2026; status: active.
02
Drugs
pilocarpine
03
Conditions
presbyopia
Beyond the preview
Go deeper on CTR20261783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261783.